Section Review: Cardiovascular and Renal: ACAT inhibitors in development

This publication has 14 references indexed in Scilit:

• Inhibition of acyl-CoA cholesterol O-acyltransferase reduces the cholesteryl ester enrichment of atherosclerotic lesions in the Yucatan micropig
  Atherosclerosis, 1993
• YM17E
  Drugs of the Future, 1993
• RP 70676: A potent systematically available inhibitor of acyl-CoA:cholesterol O-acyl transferase (ACAT)
  Bioorganic & Medicinal Chemistry Letters, 1992
• U-73482: A novel ACAT inhibitor that elevates HDL-cholesterol, lowers plasma triglyceride and facilitates hepatic cholesterol mobilization in the rat
  Atherosclerosis, 1992
• Comparison of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions. A biochemical, morphological, and morphometric evaluation.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
• HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia
  New England Journal of Medicine, 1988
• Disposition of a silicon-containing amide, an inhibitor of acyl-CoA: Cholesterol acyltransferase, in dog and rat
  Biopharmaceutics & Drug Disposition, 1987
• Mechanism of the Inhibition of Cholesterol Absorption by DL-Melinamide: Inhibition of Cholesterol Esterification
  The Japanese Journal of Pharmacology, 1986
• The effect of N-(α-Methylbenzyl) linoleamide on experimental atherosclerosis in rabbits
  Journal of Atherosclerosis Research, 1969
• Changes in Lipid Composition of Lymph During Cholesterol Absorption in the Rat
  American Journal of Physiology-Legacy Content, 1957